Addiction is a chronic disorder characterised by persistent, often difficult-to-control engagement with a substance or behaviour despite harmful consequences, with associated changes in motivation, reward processing, learning, habit formation and behavioural control. In clinical terminology, substance-related disorders are distinguished from behavioural disorders such as gambling disorder, although everyday language uses “addiction” more broadly. Addiction is not adequately explained by weak character or lack of willpower. It involves interactions among biological vulnerability, psychological processes, learning, social environment, developmental factors and exposure patterns. The condition exists on a spectrum of severity and can involve periods of remission and recurrence.
Substance addiction can involve alcohol, opioids, nicotine, stimulants, sedatives and other psychoactive substances. Repeated exposure can produce neuroadaptations affecting reward, stress and self-control systems, while learning mechanisms link particular environments, emotional states or cues with substance use. Tolerance may develop, meaning that greater exposure is required to achieve some effects, although tolerance varies by drug and effect. Physical dependence is different from addiction: dependence describes physiological adaptation that can produce withdrawal when exposure stops, whereas addiction involves impaired control and continued use despite harm. A person can therefore be physically dependent without meeting criteria for an addictive disorder.
Addiction involves reinforcement mechanisms through which rewarding or relieving experiences increase the probability of repeated behaviour. Positive reinforcement occurs when an action produces a desirable outcome, while negative reinforcement occurs when an action removes or reduces an unpleasant state. Over time, behaviour can become increasingly driven by learned cues, habits, craving and anticipated relief rather than conscious pursuit of pleasure alone. Stress and adverse circumstances can strengthen these processes. The resulting pattern can persist even when the individual understands the consequences and sincerely wants to stop, because knowledge and intention do not automatically eliminate conditioned responses or physiological adaptation.
Diagnosis of a substance-use disorder considers patterns such as impaired control, unsuccessful efforts to reduce use, substantial time devoted to obtaining or recovering from use, craving, continued use despite social or interpersonal problems, hazardous use and persistence despite physical or psychological harm. Severity is determined by the number and nature of diagnostic features rather than by a simple measure of quantity consumed. Clinical assessment also considers the substance involved, duration, functional effects, coexisting conditions and safety risks. Screening tools can identify potentially problematic use, but diagnosis requires appropriate clinical context.
Treatment can include psychological interventions, medication, peer support, social interventions and management of coexisting conditions. Cognitive behavioural approaches can address triggers, beliefs, coping strategies and behavioural patterns. Motivational approaches can help people explore ambivalence and strengthen commitment to change. For some substance-use disorders, medications can reduce withdrawal, craving or relapse risk; opioid-use disorder, for example, may be treated with medicines such as methadone or buprenorphine under appropriate clinical supervision. Treatment is individualised because different substances and circumstances require different approaches.
Recovery does not necessarily follow a linear path. Some people achieve sustained remission, while others experience recurrence after periods of improvement. A recurrence of problematic use does not invalidate previous progress but can indicate a need to reassess treatment, triggers and support. Environmental cues, stress, social networks, untreated psychiatric symptoms and access to the substance can influence relapse risk. Effective care often includes harm-reduction measures even when immediate abstinence is not achieved, because reducing overdose, infectious disease, injury or other consequences can save lives while longer-term treatment continues.
Addiction has important social and public-health dimensions. Stigma can discourage people from seeking treatment and can lead to concealment of symptoms or risky use. Addiction can affect employment, relationships, finances, physical health and housing, while its consequences can also affect families and communities. Prevention approaches include reducing harmful exposure, evidence-based education, early identification, treatment access and policies that reduce severe harms. It is important to distinguish scientifically defined disorders from casual uses of the word “addicted”, because describing an ordinary preference as addiction can obscure the clinical seriousness of genuine addictive disorders.
Addiction is related to but distinct from craving, dependence, habit and compulsive behaviour. Craving is an intense desire or urge and can occur without a full addictive disorder. Habits are learned patterns that can be automatic but are not necessarily harmful or difficult to control. Dependence is primarily a physiological adaptation and can occur with appropriately used medicines. Addiction is best understood through the combination of impaired control, persistent engagement and clinically meaningful harm or impairment. Recovery can involve abstinence, controlled goals where clinically appropriate, medication, behavioural change, social support and long-term monitoring, depending on the particular disorder and individual circumstances.
